Anupam Rasayan India Ltd. Revenue Breakdown – NSE:ANURAS
NiveshIQ
NSE: ANURAS · Chemicals
Anupam Rasayan India Ltd.
₹1,214.40▼ ₹4.00 (-0.33%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ANURAS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Anupam Rasayan India Ltd.
Anupam Rasayan India Ltd is a custom synthesis and manufacturing company of specialty chemicals with operations in India, Europe, Japan, Singapore, China, North America, and internationally. The company operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. Its key revenue drivers include life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry. The company has recently reported a 27.12% year-over-year growth in consolidated net sales to Rs 635.78 crore in March 2026. Anupam Rasayan has also made a significant acquisition by purchasing up to 43% stake in Bliss GVS Pharma for around Rs 1,369 crore. This strategic move is expected to enhance the company's presence in the pha
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,475 Cr -7.90% | ₹1,437 Cr -2.60% | ₹2,365 Cr +64.60% |
| EBITDA Margin | 25.76% | 27.89% | 22.96% |
| Net Profit | ₹167.00 Cr -23.00% | ₹160.00 Cr -4.20% | ₹222.20 Cr +38.90% |
| EPS | ₹11.72 | ₹8.49 | ₹15.09 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Anupam Rasayan India Ltd is Rated Hold by MarketsMOJO
Bliss GVS Pharma IDC recommends Anupam Rasayan open offer
🔒
+ 3 more stories about Anupam Rasayan India Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹636 Cr, PAT ₹56 Cr, EPS ₹3.75, EBITDA margin 22.1%. Growth context: revenue YoY +27.2%, PAT YoY -11.1%, revenue QoQ +24.2%, PAT QoQ -8.2%. Street verdict: miss, revenue surprise +5.5%, PAT surprise -16.1%.
Management commentary highlights new capacity additions, capex deployments, and order wins as key near-term growth drive...
FY26 (last completed FY): revenue ₹2, 365 Cr, PAT ₹222 Cr, EBITDA margin 23.0%, EPS ₹15.09. Year-on-year: revenue YoY +6...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ANURAS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ANURAS alongside your other holdings
Unlock full ANURAS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Anupam Rasayan India Ltd.?
NiveshIQ detects active intelligence signals for Anupam Rasayan India Ltd. (ANURAS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Anupam Rasayan India Ltd.?
Anupam Rasayan India Ltd. operates in the Chemicals sector with a market capitalisation of ₹1,558,583.4L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.